These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dementia and neurocognitive disorders due to HIV-1 infection. Ances BM; Ellis RJ Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745 [TBL] [Abstract][Full Text] [Related]
3. Neurocognitive disorders seen in HIV disease. Ungvarski PJ; Trzcianowska H Issues Ment Health Nurs; 2000; 21(1):51-70. PubMed ID: 10839052 [TBL] [Abstract][Full Text] [Related]
4. Evolving clinical phenotypes in HIV-associated neurocognitive disorders. Sacktor N; Robertson K Curr Opin HIV AIDS; 2014 Nov; 9(6):517-20. PubMed ID: 25203640 [TBL] [Abstract][Full Text] [Related]
6. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Goodkin K; Wilkie FL; Concha M; Asthana D; Shapshak P; Douyon R; Fujimura RK; LoPiccolo C Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968 [TBL] [Abstract][Full Text] [Related]
7. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738 [TBL] [Abstract][Full Text] [Related]
8. Updated research nosology for HIV-associated neurocognitive disorders. Antinori A; Arendt G; Becker JT; Brew BJ; Byrd DA; Cherner M; Clifford DB; Cinque P; Epstein LG; Goodkin K; Gisslen M; Grant I; Heaton RK; Joseph J; Marder K; Marra CM; McArthur JC; Nunn M; Price RW; Pulliam L; Robertson KR; Sacktor N; Valcour V; Wojna VE Neurology; 2007 Oct; 69(18):1789-99. PubMed ID: 17914061 [TBL] [Abstract][Full Text] [Related]
9. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091 [TBL] [Abstract][Full Text] [Related]
10. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268 [TBL] [Abstract][Full Text] [Related]
11. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders? Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542 [TBL] [Abstract][Full Text] [Related]
12. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. Ellis RJ; Badiee J; Vaida F; Letendre S; Heaton RK; Clifford D; Collier AC; Gelman B; McArthur J; Morgello S; McCutchan JA; Grant I; AIDS; 2011 Sep; 25(14):1747-51. PubMed ID: 21750419 [TBL] [Abstract][Full Text] [Related]
13. [Cognitive alterations associated with HIV-1 infection and AIDS]. Christo PP Rev Assoc Med Bras (1992); 2010; 56(2):242-7. PubMed ID: 20499003 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda. Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575 [TBL] [Abstract][Full Text] [Related]
15. Neurologic complications of HIV infection. Spudich SS; Ances BM Top Antivir Med; 2012; 20(2):41-7. PubMed ID: 22710906 [TBL] [Abstract][Full Text] [Related]
16. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya. Mohamed AA; Oduor C; Kinyanjui D BMC Neurol; 2020 Jul; 20(1):280. PubMed ID: 32664858 [TBL] [Abstract][Full Text] [Related]